Eid Maroua, Fouquet Olivier, Darreau Cédric, Pierrot Marc, Kouatchet Achille, Mercat Alain, Baufreton Christophe
1 Cardiac Surgery Unit, University Hospital of Angers, Angers, France.
2 Intensive Care Unit, University Hospital of Angers, Angers, France.
Int J Artif Organs. 2018 Mar;41(3):178-182. doi: 10.1177/0391398817752594. Epub 2018 Feb 20.
Necrotizing fasciitis represents a life-threatening infectious condition that causes spreading necrotisis of superficial fascia and subcutaneous cellular tissues. We describe the case of a patient diagnosed with septic and toxic shocks leading to multiple organ failure successfully treated with a combination of extracorporeal life support, continuous renal replacement therapy, and a hemoadsorption device.
A 41-year-old patient presented with necrotizing fasciitis and multi-organ failure. Initial extracorporeal life support therapy was implanted, compensating for systolic failure. Due to acute renal failure that persisted in time, continuous renal replacement therapy was added. Despite these treatments and as a last attempt to control the septic condition, a CytoSorb hemoadsorption device was installed in parallel to the extracorporeal life support circuit and two sessions were run.
During the days following CytoSorb treatment, hemodynamic stabilization was observed, as well as normalization of lactic acidosis and blood parameters.
This case describes the successful use of CytoSorb with continuous renal replacement therapy and extracorporeal life support in a combined way to overcome a critical phase of septic shock in a young adult patient. This combination of treatments turned out to be efficient for this patient in the context of necrotizing fasciitis.
坏死性筋膜炎是一种危及生命的感染性疾病,可导致浅筋膜和皮下细胞组织的弥漫性坏死。我们描述了一例被诊断为感染性和中毒性休克导致多器官功能衰竭的患者,通过体外生命支持、连续性肾脏替代治疗和血液吸附装置联合治疗成功治愈的病例。
一名41岁患者出现坏死性筋膜炎和多器官功能衰竭。最初植入体外生命支持治疗,以代偿收缩功能衰竭。由于急性肾衰竭持续存在,增加了连续性肾脏替代治疗。尽管进行了这些治疗,作为控制感染状态的最后尝试,在体外生命支持回路中并行安装了CytoSorb血液吸附装置,并进行了两个疗程。
在CytoSorb治疗后的几天里,观察到血流动力学稳定,乳酸酸中毒和血液参数也恢复正常。
本病例描述了成功联合使用CytoSorb、连续性肾脏替代治疗和体外生命支持,以克服一名年轻成年患者感染性休克的关键阶段。在坏死性筋膜炎的背景下,这种联合治疗对该患者有效。